GABAergic modulation of secondary hyperalgesia: A randomized controlled 4‐way crossover trial with the α2‐subunit preferring GABA positive allosteric modulator, N ‐desmethyl‐clobazam in healthy volunteers-Reference-Cited by-同舟云学术

GABAergic modulation of secondary hyperalgesia: A randomized controlled 4‐way crossover trial with the α2‐subunit preferring GABA positive allosteric modulator, N ‐desmethyl‐clobazam in healthy volunteers

Published:2020-04 Issue:6 Volume:24 Page:1094-1106
ISSN:1090-3801
Container-title:European Journal of Pain
language:en
Short-container-title:Eur J Pain

Author:

Matthey Alain¹,Daali Youssef¹²,Curtin François¹²,Poncet Antoine³,Desmeules Jules¹²,Besson Marie¹²

Affiliation:

1. Division of Clinical Pharmacology and Toxicology Multidisciplinary Pain Center Geneva University Hospitals Geneva Switzerland

2. Faculty of Medicine Geneva University Geneva Switzerland

3. Division of Clinical Epidemiology Geneva University Hospitals Geneva Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejp.1554

Reference42 articles.

1. Pharmacotherapy of neuropathic pain

2. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

3. Opioids for the Treatment of Chronic Pain

4. The Molecular Architecture of GABAA Receptors

5. International Union of Pharmacology. XV. Subtypes of gamma‐aminobutyric acidA receptors: Classification on the basis of subunit structure and receptor function;Barnard E. A.;Pharmacological Reviews,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KCC2 receptor upregulation potentiates antinociceptive effect of GABAAR agonist on remifentanil-induced hyperalgesia;Molecular Pain;2022-03-30

2. The orally bioavailable imidazodiazepine, KRM-II-81, is a novel potentiator of α2/3-containing GABAA receptors with analgesic efficacy;The Neurobiology, Physiology, and Psychology of Pain;2022

3. GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors;Pharmacology & Therapeutics;2021-11